US FDA Outlines Wishlist For Decentralized Clinical Trials

Companies Need Not Have An ‘All Or Nothing’ Approach

 
• By Vibha Sharma
  
Clinical trial
Decentralized Trials Have Drawn Pharma’s Interest • Source: Shutterstock

More from Clinical Trials

More from R&D